FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Registration Date 7 Nov 2022
Revision Date 7 Nov 2022
Share

XavTrap®

(0)

Medicine Medical Supplies

Cancer Detection

Manufacturer's Description

XavTrap is a recombinant platform technology using yeast cell fragments to rapidly express single-chain variable fragment (scFV), nanobodies or peptides for diagnostic applications. This platform technology can be rapidly made to target a specific disease (Disease X), including seasonal mutations of influenzas and coronavirus. Xing XavTrap® platform produces lead candidates 66% faster than cutting edge mammalian antibody pipelines, which XING has validated as part of the NIH-RADx Program*.